US Stock MarketDetailed Quotes

ALNAQ Allena Pharmaceuticals

Watchlist
  • 0.000
  • 0.0000.00%
Close Dec 14 09:30 ET
122.08Market Cap0.00P/E (TTM)

Allena Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-49.41%6.92M
1.29%11.56M
48.97%47.65M
1.36%10.12M
57.00%12.43M
108.68%13.69M
51.65%11.41M
-31.83%31.99M
-6.58%9.99M
-40.64%7.92M
Selling and administrative expenses
-18.18%2.94M
6.77%3.8M
9.26%12.68M
-29.69%2.12M
14.87%3.41M
30.75%3.6M
23.63%3.56M
19.92%11.6M
52.92%3.01M
17.14%2.97M
-General and administrative expense
-18.18%2.94M
6.77%3.8M
9.26%12.68M
-29.69%2.12M
14.87%3.41M
30.75%3.6M
23.63%3.56M
19.92%11.6M
52.92%3.01M
17.14%2.97M
Research and development costs
-60.55%3.98M
-1.20%7.76M
71.57%34.97M
14.75%8.01M
82.23%9.02M
164.97%10.09M
69.01%7.85M
-45.27%20.38M
-20.00%6.98M
-54.17%4.95M
Operating profit
49.41%-6.92M
-1.29%-11.56M
-48.97%-47.65M
-1.36%-10.12M
-57.00%-12.43M
-108.68%-13.69M
-51.65%-11.41M
31.83%-31.99M
6.58%-9.99M
40.64%-7.92M
Net non-operating interest income expense
53.36%-118K
-5.96%-249K
-91.37%-976K
4.42%-238K
-140.38%-250K
-145.63%-253K
-335.19%-235K
-288.89%-510K
-1,975.00%-249K
-296.23%-104K
Non-operating interest expense
-53.36%118K
5.96%249K
----
----
140.38%250K
145.63%253K
335.19%235K
----
----
--104K
Total other finance cost
----
----
91.37%976K
----
----
----
----
288.89%510K
----
----
Other net income (expense)
-4,253.13%-1.39M
-177.78%-7K
89.11%-38K
83.33%-4K
-175.00%-11K
89.81%-32K
228.57%9K
49.35%-349K
96.36%-24K
-33.33%-4K
Gain on sale of security
---1.02M
----
----
----
----
----
----
----
----
----
Special income (charges)
----
----
--0
----
----
----
----
--0
----
----
-Less:Restructuring and merger&acquisition
----
----
--0
----
----
----
----
--0
----
----
Other non- operating income (expenses)
-1,056.25%-370K
-177.78%-7K
89.11%-38K
83.33%-4K
-175.00%-11K
89.81%-32K
228.57%9K
-315.48%-349K
55.56%-24K
-33.33%-4K
Income before tax
39.63%-8.44M
-1.52%-11.81M
-48.16%-48.66M
-1.02%-10.36M
-58.14%-12.69M
-100.29%-13.97M
-53.41%-11.64M
30.62%-32.85M
9.69%-10.26M
39.60%-8.03M
Income tax
Net income
39.63%-8.44M
-1.52%-11.81M
-48.16%-48.66M
-1.02%-10.36M
-58.14%-12.69M
-100.29%-13.97M
-53.41%-11.64M
30.62%-32.85M
9.69%-10.26M
39.60%-8.03M
Net income continuous Operations
39.63%-8.44M
-1.52%-11.81M
-48.16%-48.66M
-1.02%-10.36M
-58.14%-12.69M
-100.29%-13.97M
-53.41%-11.64M
30.62%-32.85M
9.69%-10.26M
39.60%-8.03M
Minority interest income
Net income attributable to the parent company
39.63%-8.44M
-1.52%-11.81M
-48.16%-48.66M
-1.02%-10.36M
-58.14%-12.69M
-100.29%-13.97M
-53.41%-11.64M
30.62%-32.85M
9.69%-10.26M
39.60%-8.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.63%-8.44M
-1.52%-11.81M
-48.16%-48.66M
-1.02%-10.36M
-58.14%-12.69M
-100.29%-13.97M
-53.41%-11.64M
30.62%-32.85M
9.69%-10.26M
39.60%-8.03M
Basic earnings per share
66.67%-0.08
38.10%-0.13
28.71%-0.72
54.17%-0.11
22.73%-0.17
7.69%-0.24
32.26%-0.21
52.58%-1.01
48.94%-0.24
61.40%-0.22
Diluted earnings per share
66.67%-0.08
38.10%-0.13
28.71%-0.72
54.17%-0.11
22.73%-0.17
7.69%-0.24
32.26%-0.21
52.58%-1.01
48.94%-0.24
61.40%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -49.41%6.92M1.29%11.56M48.97%47.65M1.36%10.12M57.00%12.43M108.68%13.69M51.65%11.41M-31.83%31.99M-6.58%9.99M-40.64%7.92M
Selling and administrative expenses -18.18%2.94M6.77%3.8M9.26%12.68M-29.69%2.12M14.87%3.41M30.75%3.6M23.63%3.56M19.92%11.6M52.92%3.01M17.14%2.97M
-General and administrative expense -18.18%2.94M6.77%3.8M9.26%12.68M-29.69%2.12M14.87%3.41M30.75%3.6M23.63%3.56M19.92%11.6M52.92%3.01M17.14%2.97M
Research and development costs -60.55%3.98M-1.20%7.76M71.57%34.97M14.75%8.01M82.23%9.02M164.97%10.09M69.01%7.85M-45.27%20.38M-20.00%6.98M-54.17%4.95M
Operating profit 49.41%-6.92M-1.29%-11.56M-48.97%-47.65M-1.36%-10.12M-57.00%-12.43M-108.68%-13.69M-51.65%-11.41M31.83%-31.99M6.58%-9.99M40.64%-7.92M
Net non-operating interest income expense 53.36%-118K-5.96%-249K-91.37%-976K4.42%-238K-140.38%-250K-145.63%-253K-335.19%-235K-288.89%-510K-1,975.00%-249K-296.23%-104K
Non-operating interest expense -53.36%118K5.96%249K--------140.38%250K145.63%253K335.19%235K----------104K
Total other finance cost --------91.37%976K----------------288.89%510K--------
Other net income (expense) -4,253.13%-1.39M-177.78%-7K89.11%-38K83.33%-4K-175.00%-11K89.81%-32K228.57%9K49.35%-349K96.36%-24K-33.33%-4K
Gain on sale of security ---1.02M------------------------------------
Special income (charges) ----------0------------------0--------
-Less:Restructuring and merger&acquisition ----------0------------------0--------
Other non- operating income (expenses) -1,056.25%-370K-177.78%-7K89.11%-38K83.33%-4K-175.00%-11K89.81%-32K228.57%9K-315.48%-349K55.56%-24K-33.33%-4K
Income before tax 39.63%-8.44M-1.52%-11.81M-48.16%-48.66M-1.02%-10.36M-58.14%-12.69M-100.29%-13.97M-53.41%-11.64M30.62%-32.85M9.69%-10.26M39.60%-8.03M
Income tax
Net income 39.63%-8.44M-1.52%-11.81M-48.16%-48.66M-1.02%-10.36M-58.14%-12.69M-100.29%-13.97M-53.41%-11.64M30.62%-32.85M9.69%-10.26M39.60%-8.03M
Net income continuous Operations 39.63%-8.44M-1.52%-11.81M-48.16%-48.66M-1.02%-10.36M-58.14%-12.69M-100.29%-13.97M-53.41%-11.64M30.62%-32.85M9.69%-10.26M39.60%-8.03M
Minority interest income
Net income attributable to the parent company 39.63%-8.44M-1.52%-11.81M-48.16%-48.66M-1.02%-10.36M-58.14%-12.69M-100.29%-13.97M-53.41%-11.64M30.62%-32.85M9.69%-10.26M39.60%-8.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.63%-8.44M-1.52%-11.81M-48.16%-48.66M-1.02%-10.36M-58.14%-12.69M-100.29%-13.97M-53.41%-11.64M30.62%-32.85M9.69%-10.26M39.60%-8.03M
Basic earnings per share 66.67%-0.0838.10%-0.1328.71%-0.7254.17%-0.1122.73%-0.177.69%-0.2432.26%-0.2152.58%-1.0148.94%-0.2461.40%-0.22
Diluted earnings per share 66.67%-0.0838.10%-0.1328.71%-0.7254.17%-0.1122.73%-0.177.69%-0.2432.26%-0.2152.58%-1.0148.94%-0.2461.40%-0.22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg